Robert Osborne

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV.

Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.

Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.

BioHelix Corp. operates as a molecular diagnostic company, that develops nucleic acid technologies for molecular diagnostics. The firm focuses on the development of simple molecular diagnostic tests for the near patient setting. It offers in vitro diagnostic products, such as IsoAmp, an herpes simplex viruses (HSV) assay test for the direct, qualitative detection of HSV DNA in male and female genital and oral lesions. The company was founded by Huimin Kong in 2004 and is headquartered in Beverly, MA.

BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA.

Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA.

Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France.

Stratos Genomics, Inc. develops nucleic acid sequencing methods. The firm's Sequencing by Expansion (SBX) solution offers a single-molecule detection process that allows whole genome sequencing. The company was founded by Allan H. Stephan, Mark Kokoris, and Robert McRuer in 2007 and is headquartered in Seattle, WA.

Akili Interactive Labs, Inc. develops therapeutic mobile video games. It also develops platform technology that test and enhance the cognitive abilities through a video game. The company was founded by Adam Gazzaley, Daphne Zohar, Daphne Bavelier, and Eddie Martucci in 2011 and is headquartered in Boston, MA.

ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

GestVision, Inc. provides care diagnostic test for preeclampsia. The firm delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. It is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Groton, CT.

Apton Biosystems, Inc. engages in the provision of health care services with focus on biotechnology business. The company was founded in 2012 and is headquartered in Pleasanton, CA.

Spinomix SA develops a software technology platform. The private company is based in Lausanne, Switzerland and has subsidiaries in Switzerland.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

MOBILion Systems, Inc. offers paradigm-shifting platform technology. It will Develop a cost effective analytical system with a small footprint, high throughput, ultra-high sensitivity and selectivity enabling use in commercial applications unattainable by conventional ion mobility separation devices. The company was founded in 2015 and is headquartered in , Chadds Ford, PA.

Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA.

MedCision LLC provides medical related software solutions. Its products include ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems and Custom ULT Freezer Storage Boxes. The firm develops and commercializes technologies that automate and standardize preclinical and clinical biologics handling for critical post-manufacturing processes. The company was founded by Rolf O. Ehrhardt in 2016 and is headquartered in San Rafael, CA.

Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA.